Karl Doghramji, MD, FAASM, DFAPA

Experts explain why most narcolepsy patients need combination therapy, not one pill, and how new agents cut daytime sleepiness toward normal.

Learn how DEA scheduling shapes narcolepsy treatment choices, and why emerging orexin agonists may transform daytime sleepiness and cataplexy care.

Experts explain which narcolepsy meds suit kids—oxybates and pitolisant approvals, stimulant side effects, and key heart-safety checks.

Explore today’s narcolepsy care: from sleep hygiene to stimulants, oxybates, and pitolisant—targeting sleepiness and cataplexy.

Explore today’s narcolepsy care: wake-promoting meds, oxybates for cataplexy, and pitolisant’s histamine boost—plus sleep habits that matter.

Please paste the article text (or an excerpt). If you share the title too, I’ll avoid mirroring it while crafting a 150-character, ≤24-word meta description.

Learn how narcolepsy mimics ADHD, seizures and depression, plus key clues, comorbid risks, and genetic triggers behind chronic sleepiness.

Narcolepsy is more common than thought—often missed in sleep clinics, mistaken for ADHD or depression, causing 10–15 year delays.

Learn how narcolepsy shows up: true daytime sleepiness, subtle cataplexy, vivid dreams—and why kids are often misread as ADHD.

In this episode, 'Recognizing Narcolepsy Across the Lifespan', the experts explore the clinical presentation of narcolepsy, beginning with the one symptom universal to all patients: excessive daytime sleepiness.

In this episode titled, 'Understanding Narcolepsy as More Than a Sleep Disorder', the moderator, Dr. Karl Doghramji, led the conversation about excessive daytime sleepiness as a widespread clinical challenge, with the expert panel narrowing the focus to narcolepsy, a central disorder of hypersomnolence that is frequently missed in practice